Clinical Outcome of Standardized 177Lu-Psma-617 Therapy in Metastatic Prostate Cancer Patients Receiving 7400 MBq Every 4 Weeks
European Journal of Nuclear Medicine and Molecular Imaging - Germany
doi 10.1007/s00259-019-04584-1
Full Text
Open PDFAbstract
Available in full text
Date
November 28, 2019
Authors
Publisher
Springer Science and Business Media LLC